Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase 1b investigation of the MEK inhibitor binimetinib in patients with advanced or metastatic biliary tract cancer.AuthorsFinn, R. S.; Ahn, D. H.; Javle, M. M.; Tan, B. R.; Weekes, C. D.; Bendell, J. C.; Patnaik, A.; Khan, G. N.; Laheru, D.; Chavira, R.; Christy-Bittel, J.; Barrett, E.; Sawyer, M. B.; Bekaii-Saab, Tanios S.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 6, p1037ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0600-2